From the desks

Deployment tracker

Who deployed it, what went live, and the number that matters.

Deployments
1
Live
0
Added this month
0

1 deploymentsDownload all (CSV)

  1. Caris Life SciencesAI-based molecular signature16.0median overall survival (months)
    Function
    Treatment selection
    Built on
    Whole Exome Sequencing, Whole Transcriptome Sequencing
    hazard ratio
    0.48
    survival with gem/nab-p
    13.3 months
    FDA approval date
    November 2024
    study publication
    npj Precision Oncology

    Source: Caris AI Study Links Treatment Selection to Longer Survival in Pancreatic Cancer →Caris Life Sciences →Deployment record →

Submit a deployment +

MachineCon USA · from AIM Media House

Where enterprise AI is decided

An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.

  • New York5th edition · 583 Park Avenue
  • Dallas1st edition

Register for MachineCon USASee MachineCon USA →

  • Keynote on the main stage, MachineCon New York 2025
  • AI150 award winners on stage, MachineCon New York 2025
  • At the tables, MachineCon New York 2025
  • Networking, MachineCon New York 2025